Vaxart (OTCMKTS:VXRT) used its fourth-quarter business update and year-end 2025 financial results conference call to highlight a new partnership for its oral COVID-19 vaccine candidate, updates on an ...
ADENTRA (TSE:ADEN) executives said the company delivered “steady results” in 2025 despite a “relatively muted” North American construction environment, emphasizing margin discipline, cost actions, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results